Fintel reports that on February 13, 2025, Leerink Partners upgraded their outlook for CVS Health (NYSE:CVS) from Market ...

CEO David Joyner has an ambitious plan to revamp the company's retail healthcare business and create a more integrated system ...

Managers are increasingly suspicious of AI-generated applications, fearing inaccurate reflections of a candidate's skills.

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...